Sugi Pharmacy
Sugi Pharmacy, officially known as Sugi Holdings Co., Ltd., is a prominent player in the Japanese pharmaceutical industry, headquartered in Japan. Established in 1976, the company has grown significantly, operating over 1,000 pharmacies across major regions, including Kanto and Kansai. Specialising in prescription medications, over-the-counter drugs, and health-related products, Sugi Pharmacy distinguishes itself through its commitment to customer service and community health. The company has achieved notable milestones, including the introduction of innovative health management services that cater to the evolving needs of its clientele. With a strong market position, Sugi Pharmacy is recognised for its extensive product range and dedication to enhancing the well-being of its customers, making it a trusted name in the healthcare sector.
DitchCarbon Score
How does Sugi Pharmacy's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sugi Pharmacy's score of 22 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sugi Pharmacy's reported carbon emissions
Sugi Pharmacy, headquartered in Japan, has made significant strides in understanding and managing its carbon emissions. In 2022, the company reported approximately 1,715,396,000 kg CO2e in Scope 3 emissions, which primarily stem from purchased goods and services, accounting for about 1,601,452,000 kg CO2e. This figure highlights the substantial impact of their supply chain on overall emissions. In previous years, Sugi Pharmacy's emissions have shown variability. For instance, in 2021, the total emissions were approximately 1,700,421,000 kg CO2e, with Scope 1 emissions at about 1,832,000 kg CO2e and Scope 2 emissions at approximately 133,316,000 kg CO2e. The company has not disclosed specific reduction targets or initiatives, indicating a potential area for future commitment. Despite the lack of formal reduction targets, Sugi Pharmacy's emissions data reflects a growing awareness of climate impact, particularly in Scope 3 emissions, which are often the most challenging to manage. The company’s ongoing efforts to assess and report its carbon footprint are crucial steps towards enhancing sustainability and addressing climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 1,769,000 | 0,000,000 | 0,000,000 | - |
| Scope 2 | 115,841,000 | 000,000,000 | 000,000,000 | - |
| Scope 3 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sugi Pharmacy is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
